Sign in
Effect of 6 month anti-VEGF treatment for proliferative diabetic retinopathy on the quantitative metrics of the retinal microvasculature on OCTA
Quan V. Hoang, MD, PhD
On Demand Cases, Courses, and Papers
2019
ORBIT: A Phase IV Clinical Study - Lessons Learned From Patient Selection Criteria for Ocriplasmin Intravitreal Injection
Mathew W. MacCumber, MD, PhD
Annual Meeting Talks
2016
Episode 25: RIVAL Study: Ranibizumab vs Aflibercept in T&E for wet AMD with Dr. Mark Gillies
Keyvan Koushan, MD, FRCSC
Member Podcasts
Category: AMD-Neovascular